UB Paderborn / Katalog / Suche / in CDI

Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (6), p.3271-3277

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical development of histone deacetylase inhibitors as anticancer agents

Annual review of pharmacology and toxicology, 2005-01, Vol.45 (1), p.495-528

2005

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo

Cancer research (Chicago, Ill.), 2005-12, Vol.65 (24), p.11631-11638

2005

Link zum Volltext

Verfügbarkeit prüfen

Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors

Pharmacological reviews, 1999-12, Vol.51 (4), p.691

1999

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells

Cancer research (Chicago, Ill.), 2003-06, Vol.63 (12), p.3154-3161

2003

Link zum Volltext

Verfügbarkeit prüfen

Anti-HER2 immunoliposomes: Enhanced efficacy attributable to targeted delivery

Clinical cancer research, 2002-04, Vol.8 (4), p.1172-1181

2002

Link zum Volltext

Verfügbarkeit prüfen

Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors : Pharmacology and efficacy

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (5), p.2801-2806

2006

Link zum Volltext

Verfügbarkeit prüfen

Tumor targeting using anti-her2 immunoliposomes

Journal of controlled release, 2001-07, Vol.74 (1), p.95-113

2001

Link zum Volltext

Verfügbarkeit prüfen

Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging

Cancer research (Chicago, Ill.), 2004-04, Vol.64 (7), p.2572-2579

2004

Link zum Volltext

Verfügbarkeit prüfen

Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain

Experimental neurology, 2005-12, Vol.196 (2), p.381-389

2005

Link zum Volltext

Verfügbarkeit prüfen

Liposome-based approaches to overcome anticancer drug resistance

Drug resistance updates, 2003-10, Vol.6 (5), p.271-279

2003

Link zum Volltext

Verfügbarkeit prüfen

Mapping tumor epitope space by direct selection of single-chain Fv antibody libraries on prostate cancer cells

Cancer research (Chicago, Ill.), 2004-01, Vol.64 (2), p.704-710

2004

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis

Biochimica et biophysica acta, 2002-08, Vol.1591 (1), p.109-118

2002

Link zum Volltext

Verfügbarkeit prüfen

Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery

Gene therapy, 2006-04, Vol.13 (7), p.646-651

2006

Link zum Volltext

Verfügbarkeit prüfen

Development of ligand-targeted liposomes for cancer therapy

Expert opinion on therapeutic targets, 2004-08, Vol.8 (4), p.335-353

2004

Link zum Volltext

Verfügbarkeit prüfen

Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery

Journal of neuro-oncology, 2004-05, Vol.68 (1), p.1-9

2004

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Manufacture of an Anti-HER2 scFv-PEG-DSPE, Liposome-Inserting Conjugate. 1. Gram-Scale Production and Purification

Biotechnology progress, 2005, Vol.21 (1), p.205-220

2005

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Manufacture of Anti-HER2 Liposome-Inserting, scFv-PEG-Lipid Conjugate. 2. Conjugate Micelle Identity, Purity, Stability, and Potency Analysis

Biotechnology progress, 2005, Vol.21 (1), p.221-232

2005

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer

Journal of magnetism and magnetic materials, 1993-04, Vol.122 (1), p.374-378

1993

Link zum Volltext

Verfügbarkeit prüfen

Anti-HER2 immunoliposomes for targeted therapy of human tumors

Cancer letters, 1997-10, Vol.118 (2), p.153-160

1997

Link zum Volltext

Verfügbarkeit prüfen

Biological Effects of Anti-ErbB2 Single Chain Antibodies Selected for Internalizing Function

Biochemical and biophysical research communications, 2001-01, Vol.280 (1), p.274-279

2001

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-14-09: Preclinical Safety and Activity of MM-302, a HER2-Targeted Liposomal Doxorubicin Designed To Have an Improved Safety and Efficacy Profile over Approved Anthracyclines

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P3-P3-14-09

2010

Link zum Volltext

Verfügbarkeit prüfen

Anti-HER2 Immunoliposomes for Targeted Drug Delivery

Annals of the New York Academy of Sciences, 1999-01, Vol.886 (1), p.293-296

1999

Link zum Volltext

Verfügbarkeit prüfen

Targeting of Drugs to Solid Tumors Using Anti-Her2 Immunoliposomes

Journal of liposome research, 1998-01, Vol.8 (4), p.425-442

1998

Link zum Volltext

Verfügbarkeit prüfen

Targeting of Liposomes to Solid Tumors: The Case of Sterically Stabilized Anti-Her2 Immunoliposomes

Journal of liposome research, 1997-01, Vol.7 (4), p.391-417

1997

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy

Clinical development of histone deacetylase inhibitors as anticancer agents

Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo

Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors

Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells

Anti-HER2 immunoliposomes: Enhanced efficacy attributable to targeted delivery

Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors : Pharmacology and efficacy

Tumor targeting using anti-her2 immunoliposomes

Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging

Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain

Liposome-based approaches to overcome anticancer drug resistance

Mapping tumor epitope space by direct selection of single-chain Fv antibody libraries on prostate cancer cells

Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis

Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery

Development of ligand-targeted liposomes for cancer therapy

Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery

Preclinical Manufacture of an Anti-HER2 scFv-PEG-DSPE, Liposome-Inserting Conjugate. 1. Gram-Scale Production and Purification

Preclinical Manufacture of Anti-HER2 Liposome-Inserting, scFv-PEG-Lipid Conjugate. 2. Conjugate Micelle Identity, Purity, Stability, and Potency Analysis

Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer

Anti-HER2 immunoliposomes for targeted therapy of human tumors

Biological Effects of Anti-ErbB2 Single Chain Antibodies Selected for Internalizing Function

Abstract P3-14-09: Preclinical Safety and Activity of MM-302, a HER2-Targeted Liposomal Doxorubicin Designed To Have an Improved Safety and Efficacy Profile over Approved Anthracyclines

Anti-HER2 Immunoliposomes for Targeted Drug Delivery

Targeting of Drugs to Solid Tumors Using Anti-Her2 Immunoliposomes

Targeting of Liposomes to Solid Tumors: The Case of Sterically Stabilized Anti-Her2 Immunoliposomes

Suchergebnisse filtern